Cargando…
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
BACKGROUND: Direct oral anticoagulants (DOACs) are recommended as first-line anticoagulants in patients with atrial fibrillation (AF). However, in patients with cancer and AF the efficacy and safety of DOACs are not well established. OBJECTIVE: We performed a meta-analysis comparing available data r...
Autores principales: | Mariani, Marco Valerio, Magnocavallo, Michele, Straito, Martina, Piro, Agostino, Severino, Paolo, Iannucci, Gino, Chimenti, Cristina, Mancone, Massimo, Rocca, Domenico Giovanni Della, Forleo, Giovanni Battista, Fedele, Francesco, Lavalle, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886836/ https://www.ncbi.nlm.nih.gov/pubmed/33044735 http://dx.doi.org/10.1007/s11239-020-02304-3 |
Ejemplares similares
-
Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
por: Lavalle, Carlo, et al.
Publicado: (2022) -
Catheter ablation for papillary muscle arrhythmias: A systematic review
por: Mariani, Marco Valerio, et al.
Publicado: (2022) -
Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019) -
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy
por: Chimenti, Cristina, et al.
Publicado: (2021) -
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias
por: Pandozi, C., et al.
Publicado: (2022)